A Castot

1.5k total citations
61 papers, 897 citations indexed

About

A Castot is a scholar working on Toxicology, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, A Castot has authored 61 papers receiving a total of 897 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Toxicology, 12 papers in Pediatrics, Perinatology and Child Health and 7 papers in Pharmacology. Recurrent topics in A Castot's work include Pharmacovigilance and Adverse Drug Reactions (14 papers), Pharmaceutical studies and practices (9 papers) and Drug-Induced Hepatotoxicity and Protection (7 papers). A Castot is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (14 papers), Pharmaceutical studies and practices (9 papers) and Drug-Induced Hepatotoxicity and Protection (7 papers). A Castot collaborates with scholars based in France, Belize and Guatemala. A Castot's co-authors include Thierry Vial, Nicholas Moore, Dominique Larrey, M Biour, Henri Michel, Dominique Larrey, Arnaud Pauwels, Emmanuel Lagarde, Pierre Philip and Ludivine Orriols and has published in prestigious journals such as The Lancet, Annals of Internal Medicine and Hepatology.

In The Last Decade

A Castot

58 papers receiving 829 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Castot France 14 278 139 131 124 97 61 897
Cathi Dennehy United States 16 199 0.7× 207 1.5× 53 0.4× 106 0.9× 44 0.5× 33 941
N. A. Klitgaard Denmark 20 89 0.3× 51 0.4× 31 0.2× 157 1.3× 67 0.7× 68 1.1k
Candy Tsourounis United States 17 129 0.5× 230 1.7× 46 0.4× 123 1.0× 24 0.2× 47 825
Mark J. Goldberg United States 21 345 1.2× 17 0.1× 144 1.1× 346 2.8× 61 0.6× 49 1.6k
Taofikat B. Agbabiaka United Kingdom 10 115 0.4× 155 1.1× 164 1.3× 124 1.0× 30 0.3× 12 666
Giada Crescioli Italy 16 69 0.2× 61 0.4× 93 0.7× 123 1.0× 50 0.5× 65 770
Niccolò Lombardi Italy 16 72 0.3× 60 0.4× 99 0.8× 124 1.0× 45 0.5× 80 654
Bhupinder Singh Kalra India 14 149 0.5× 44 0.3× 28 0.2× 131 1.1× 55 0.6× 31 854
D R Jarvie United Kingdom 19 212 0.8× 22 0.2× 147 1.1× 141 1.1× 59 0.6× 37 913
Henry Matthew United Kingdom 18 625 2.2× 18 0.1× 62 0.5× 114 0.9× 124 1.3× 58 1.6k

Countries citing papers authored by A Castot

Since Specialization
Citations

This map shows the geographic impact of A Castot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Castot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Castot more than expected).

Fields of papers citing papers by A Castot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Castot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Castot. The network helps show where A Castot may publish in the future.

Co-authorship network of co-authors of A Castot

This figure shows the co-authorship network connecting the top 25 collaborators of A Castot. A scholar is included among the top collaborators of A Castot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Castot. A Castot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Durrieu, Geneviève, Aurore Palmaro, Laure Pourcel, et al.. (2012). First French Experience of ADR Reporting by Patients After a Mass Immunization Campaign with Influenza A (H1N1) Pandemic Vaccines. Drug Safety. 35(10). 845–854. 2 indexed citations
2.
Lebrun‐Vignes, Bénédicte, C. Kreft-Jaïs, A Castot, & O. Chosidow. (2012). Comparative analysis of adverse drug reactions to tetracyclines: results of a French national survey and review of the literature. British Journal of Dermatology. 166(6). 1333–1341. 36 indexed citations
3.
Durrieu, Geneviève, Aurore Palmaro, Laure Pourcel, et al.. (2012). First French Experience of ADR Reporting by Patients After a Mass Immunization Campaign with Influenza A (H1N1) Pandemic Vaccines. Drug Safety. 35(10). 845–854. 21 indexed citations
4.
Orriols, Ludivine, Pierre Philip, Nicholas Moore, et al.. (2011). Benzodiazepine-Like Hypnotics and the Associated Risk of Road Traffic Accidents. Clinical Pharmacology & Therapeutics. 89(4). 595–601. 87 indexed citations
5.
Lagarde, Emmanuel, Blandine Gadegbeku, Bernard Delorme, et al.. (2011). Road traffic crashes and prescribed methadone and buprenorphine: A french registry-based case–control study. Drug and Alcohol Dependence. 123(1-3). 91–97. 40 indexed citations
6.
Orriols, Ludivine, Louis‐Rachid Salmi, Pierre Philip, et al.. (2009). The impact of medicinal drugs on traffic safety: a systematic review of epidemiological studies. Pharmacoepidemiology and Drug Safety. 18(8). 647–658. 92 indexed citations
7.
8.
Jacqz-Aigrain, Évelyne, Véronique Lamarque, E. Autret‐Leca, et al.. (2006). Méthodes de surveillance et de gestion des risques des médicaments pour la future mère, l’embryon, le fœtus et le nouveau-né. Therapies. 61(4). 287–295. 2 indexed citations
9.
Jacqz-Aigrain, Évelyne, Véronique Lamarque, E. Autret‐Leca, et al.. (2006). Risk Management and Monitoring Methods for the Future Mother, Embryo, Fetus, and post-natal Consequences. Therapies. 61(4). 297–304. 2 indexed citations
10.
Castot, A, et al.. (1996). [Hypersensitivity to glucocorticoids: reflections on a published case report sample].. PubMed. 50(5). 439–46. 1 indexed citations
11.
Tréchot, P., et al.. (1994). Control of massive bleeding of a pancreatic pseudoaneurysm penetrating into the colon by transcatheter arterial embolization.. PubMed. 89(8). 1268–1268. 11 indexed citations
12.
Maignen, F., et al.. (1993). [Acute toxicity of zidovudine. Analysis of the literature and number of cases at the Paris Poison Control Center].. PubMed. 48(2). 129–31. 3 indexed citations
13.
Larrey, Dominique, Thierry Vial, Arnaud Pauwels, et al.. (1992). Hepatitis after Germander (Teucrium chamaedrys) Administration: Another Instance of Herbal Medicine Hepatotoxicity. Annals of Internal Medicine. 117(2). 129–132. 206 indexed citations
14.
Castot, A, et al.. (1990). [Amineptin abuse. Analysis of 155 cases. An evaluation of the official cooperative survey of the Regional Centers of Pharmacovigilance].. PubMed. 45(5). 399–405. 13 indexed citations
15.
Abhay, K, et al.. (1990). Acute thrombotic accident in the postpartum period in a patient receiving bromocriptine. Critical Care Medicine. 18(10). 1180–1180. 11 indexed citations
16.
Larrey, Dominique, Alain Berson, François Habersetzer, et al.. (1989). Genetic predisposition to drug hepatotoxicity: Role in hepatitis caused by amineptine, a tricyclic antidepressant. Hepatology. 10(2). 168–173. 33 indexed citations
17.
Merigot, P, et al.. (1987). [Increased information role of a regional drug monitoring center].. PubMed. 41(5). 379–81. 1 indexed citations
18.
Poulet, B., et al.. (1985). [Severe complications arising from the prescription of pyrimethamine for infants being treated for toxoplasmosis].. PubMed. 40(5). 357–9. 3 indexed citations
19.
Lefébure, B., et al.. (1985). [Hepatitis from antidepressants. Evaluation of cases from the French Association of Drug Surveillance Centers and the Technical Committee].. PubMed. 39(5). 509–16. 5 indexed citations
20.
Lefébure, B., et al.. (1984). Hépatites aux antidépresseurs. Bilan des observations de l'Association Française des Centres de Phamacovigilance et de la Commission Technique.. Therapies. 39(5). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cathi Dennehy Breakdown of academic impact, for papers by N. A. Klitgaard Breakdown of academic impact, for papers by Candy Tsourounis Breakdown of academic impact, for papers by Mark J. Goldberg Breakdown of academic impact, for papers by Taofikat B. Agbabiaka Breakdown of academic impact, for papers by Giada Crescioli Breakdown of academic impact, for papers by Niccolò Lombardi Breakdown of academic impact, for papers by Bhupinder Singh Kalra Breakdown of academic impact, for papers by D R Jarvie Breakdown of academic impact, for papers by Henry Matthew
Rankless by CCL
2026